MYRIAD GENETICS INC (MYGN) Stock Income Statement
USA - NASDAQ:MYGN - US62855J1043 - Common Stock
7.4 USD
-0.1 (-1.33%)
7.39 USD
-0.01 (-0.14%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 832.90M | 837.60M | 753.20M | 678.40M | 690.60M | |||
| Minority Interest Expense | N/A | N/A | N/A | N/A | 0.00 | |||
| Cost Of Goods | 247.00M | 252.00M | 236.00M | 202.00M | 197.60M | |||
| Gross Profit | 586.70M | 585.40M | 517.00M | 476.40M | 493.00M | |||
| Operating Expenses | 661.80M | 674.00M | 654.00M | 600.10M | 619.70M | |||
| Research and Development | 113.80M | 113.40M | 88.70M | 85.40M | 81.90M | |||
| Selling, General, and Administrative Expenses | 550.00M | 560.00M | 565.00M | 514.70M | 537.80M | |||
| Operating Income | -75.80M | -88.00M | -136.00M | -123.70M | -126.70M | |||
| Interest Income/Expense | -2.60M | -1.10M | -400.00K | -600.00K | -5.90M | |||
| Other Income/Expense | -500.00K | -1.10M | -4.40M | 600.00K | -600.00K | |||
| Non Recurring Items | N/A | -33.00M | -121.00M | -16.90M | 76.70M | |||
| Income Before Taxes | -420.00M | -124.00M | -262.00M | -140.60M | -57.10M | |||
| Income Tax | -24.80M | 3.80M | 1.10M | -28.60M | -32.60M | |||
| Net Income | -396.10M | -127.00M | -263.00M | -112.00M | -27.20M | |||
| EBITDA | -16.80M | -27.00M | -74.00M | -71.00M | -63.90M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -4.28 | -1.41 | -3.18 | -1.39 | -0.34 | |||
| Non GAAP EPS | 0.11 | 0.13 | -0.28 | -0.30 | 0.02 | |||
| Statistics | ||||||||
| Gross Profit Margin | 70.44% | 69.89% | 68.64% | 70.22% | 71.39% | |||
| Profit Margin | -47.56% | -15.16% | -34.92% | -16.51% | -3.94% | |||
| Operating Profit Margin | -9.10% | -10.51% | -18.06% | -18.23% | -18.35% | |||
All data in USD